Prevalence of Antibiotic Resistance to Isonicotinylhydrazide and Rifampicin in Culture Positive Pulmonary Tuberculosis Patients from ۲۰۱۴ to ۲۰۱۶ in Zahedan City, Iran

  • سال انتشار: 1398
  • محل انتشار: مجله اقدامات و تحقیقات بیمارستانی، دوره: 4، شماره: 2
  • کد COI اختصاصی: JR_HPR-4-2_003
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 119
دانلود فایل این مقاله

نویسندگان

Seyed Mohammad Hashemi Shahri

Infectious Diseases and Tropical Medicine Research Center, Zahedan University of Medical Sciences, Zahedan, Iran

Fatemeh Fardoust

Infectious Diseases and Tropical Medicine Research Center, Zahedan University of Medical Sciences, Zahedan, Iran

Shokoufeh Mogharabi Ostad Kalayeh

Faculty of Nursing, Islamic Azad University, Iranshahr Branch, Iranshahr, Iran

Mohammad Ghenaatpisheh Sanani

Faculty of Medical Sciences, Zahedan Branch, Islamic Azad University, Zahedan, Iran

چکیده

Background: One third of the world’s population is infected with TB, and the disease is known as the second deadly global infection, even more severe than measles. The disease kills about ۲ million people a year. Approximately ۸ million people in the world are affected by advanced tuberculosis (TB). Objective: The current study aimed to determine the frequency of resistance to the antibiotics isoniazid and rifampin in positive culture pulmonary TB patients in Zahedan city during ۲۰۱۳-۲۰۱۶. Methods: This descriptive cross-sectional study studied ۱۰۰ samples from patients who referred to Boo-Ali hospital of Zahedan city from ۲۰۱۴ to ۲۰۱۶. First, the isoniazid solution was prepared, and then the rifampin solution was prepared. After that, ۲۰۰ μL of mycobacterium suspension was added to the antibiotic and antibiotic-free control. Results: Of ۱۰۰ patients participating in the study, ۵۰ (۵۰%) were male and ۵۰ (۵۰%) were female. Participants had an average age of ۵۱.۶۹ ± ۲۰.۴۱ years (۹۵-۱۲ years), ۷۹ (۷۹%) were Iranians and ۲۱ (۲۱%) were Afghans. Of the ۱۰۰ samples, ۵۵ (۵۵%) were from the year ۲۰۱۳, ۲۱ (۲۱%) were from ۲۰۱۴, ۱۰ (۱۰%) were from ۲۰۱۵, and ۱۴ (۱۴%) were from year ۲۰۱۶. The samples examined showed that ۴ (۴%) were resistant and ۹۶% were sensitive. Conclusion: The results of the current study showed that out of ۱۰۰ samples, ۴ cases (۴%) had resistance and ۹۶% were sensitive; ۲% were resistant to isoniazid, and ۲% were resistant to isoniazid and rifampin.

کلیدواژه ها

Pulmonary tuberculosis, Drug resistance, Tuberculosis (TB)

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.